Large granular lymphocytic leukemia
Large granular lymphocytic leukemia (LGLL), first proposed in 1977, is a chronic neutropenic clinical syndrome with an increase in peripheral blood large granular lymphocytes.
-
Site of disease:
Lymph blood vessels bone marrow -
Infectious :
Not contagious -
Frequent population:
Common in older patients -
Related symptoms:
Persistent fever Night sweats Enlarged liver Recurrent infections Swollen lymph nodes -
Concurrent disease:
Related Drugs
Cyclosporine Injection
Indication: For treatment: 1. Organ transplantation: 1) Prevention of rejection of kidney, liver, heart, combined heart-lung, lung and pancreas transplants. 2) Treatment of transplant rejection in patients before receiving other immunosuppressants. Due to the risk of allergy to this product (see Precautions), this product can only be intravenously infused when oral administration is not possible (such as just after surgery) or gastrointestinal absorption is impaired. Such patients should switch to oral cyclosporine treatment as soon as possible; 2. Bone marrow transplantation: 1) Prevention of rejection after transplantation. 2) Initial prevention and treatment of graft-versus-host disease (GVHD).
Manufacturer:
Cisen Pharmaceutical Co., Ltd.
Related Ingredients